Korean J Intern Med Search

  • HOME
  • Browse Articles
  • Korean J Intern Med Search
Hemato-oncology
Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study
Korean J Intern Med. 2023;38(5):734-746.   Published online June 20, 2023
Full Text     PubReader     ePub     PDF     Supplementary
Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma
Korean J Intern Med. 2023;38(4):578-578.   Published online June 9, 2023
Full Text     PubReader     ePub     PDF
Hemato-oncology
Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma [corrected-article]
Korean J Intern Med. 2023;38(2):238-247.   Published online January 26, 2023
Full Text     PubReader     ePub     PDF     Supplementary
Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study
Korean J Intern Med. 2021;36(6):1471-1485.   Published online September 24, 2021
Full Text     PubReader     ePub     PDF     Supplementary
New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients
Korean J Intern Med. 2018;33(2):435-437.   Published online March 7, 2016
Full Text     PubReader     ePub     PDF

Korean Journal of
Internal Medicine

Print ISSN: 1226-3303
Online ISSN: 2005-6648


Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by Korean Association of Internal Medicine.

Close layer
prev next